COLUMBIA, Md.--(BUSINESS WIRE)--CELSION CORPORATION (NASDAQ: CLN) today announced that Dr. Ellen Jones, a Radiation Oncologist at Duke Medical Center, has been invited to present updated interim data from the current ThermoDox® study involving patients with Recurrent Chest Wall Breast Cancer (RCW) at the 10th International Congress on Hyperthermic Oncology. The meeting, held in association with the European Society of Hyperthermic Oncology, The Society of Thermal Medicine and The Asia Society of Hyperthermic Oncology, will take place in Munich, Germany in April 2008. Dr. Jones will present preliminary safety and clinical activity data derived from the current RCW study being conducted at Duke Medical Center.
